Drug Type Small molecule drug |
Synonyms cyclo[Ala-D-Ala-N(Me)Leu-Leu-N(Me)Val-N(Me)Bmt(E)-Thr-D-N(Me)Ala-N(Me)Thr(Me)-Leu-N(Me)Leu], ASP 5286 |
Target |
Action inhibitors |
Mechanism PPI inhibitors(Cyclophilin peptidylprolyl isomerases inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC62H111N11O14 |
InChIKeyMRNNXUQYWPWWHD-SEDBRQCOSA-N |
CAS Registry935735-70-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Preclinical | Japan | 01 Aug 2020 |